27th January 2017, Volume 130 Number 1449

Gary Reynolds, Nicola Grant, Simon Thornley, Michael Hale

Pertussis (whooping cough) is characterised by a prolonged illness with severe forceful coughing occurring in paroxysms, leading to vomiting, cyanosis and can be fatal. Pertussis in infants under one year…

Subscriber content

The full contents of this page is only available to subscribers.

To view this content please login or subscribe

Author Information

Gary Reynolds, General Practitioner, Auckland Regional Public Health, ADHB, Auckland; Nicola Grant, Public Health Nurse, Auckland Regional Public Health, ADHB, Auckland; Simon Thornley, Epidemiologist, Auckland; Michael Hale, Medical Officer of Health, Auckland Regional Public Health, ADHB, Auckland.

Acknowledgements

The authors would like to thank the medical, nursing and administrative staff at ARPHS involved with pertussis notification investigation.

Correspondence

Gary Reynolds, ARPHS, Auckland District Health Board, Auckland.

Correspondence Email

garyr@adhb.govt.nz

Competing Interests

Nil.

References

  1. Clark TA. Changing Pertussis Epidemiology: Everything Old is New Again. J Infect Dis. (2014) 209 (7):978–981.
  2. Mortality and morbidity of pertussis in children and young people in New Zealand Special report 2002–14 Child and Youth Mortality Review Committee, Te Ro- pu- Arotake Auau Mate o te Hunga Tamariki, Taiohi. 2015. Mortality and morbidity of pertussis in children and young people in New Zealand: Special report 2002–14. Wellington: Child and Youth Mortality Review Committee. 
  3. Nowlan M, Turner N, Kiedrzynski T, Murfitt D, Sawicki N. Pertussis control strategies: A consistent approach for New Zealand. Synopsis of Ministry of Health Workshop, April 2015. NZ Med J; 2016: 129 (1433) 78–85.
  4. Healy CM, Munoz FM, Rench MA, Halasa NB, Edwards K, Baker CJ. Prevalence of Pertussis Antibodies in Maternal Delivery, Cord, and Infant Serum J Infect Dis 2004; 190:335–40. 
  5. Pertussis immunisation in pregnancy: Best Practice Journal Issue 60:34–37.
  6. Radke S, Petousis-Harris H, Watson D, Gentles D, Turner N. Age-specific effectiveness following each dose of acellular pertussis vaccine among infants and children in New Zealand. Vaccine. 2016 in press.
  7. Donegan K, King B, Bryan P. Safety of pertussis vaccination in pregnant women in UK: observational study BMJ 2014; 349:g4219 doi: 10.1136/bmj.g4219.
  8. Petousis-Harris H, Walls T, Watson D, Paynter J, Graham P, Turner N. Safety of Tdap vaccine in pregnant women: an observational study BMJ Open 2016; 6:e010911.doi: 10.1136/bmjopen-2015-010911.
  9. Dabrera G, Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, Fry NK, Ramsay M. A Case-Control Study to Estimate the Effectiveness of Maternal Pertussis Vaccination in Protecting Newborn Infants in England and Wales, 2012–2013. Clin Infect Dis. (2015) 60 (3):333–337.
  10. Polewicz M, Gracia A, Buchanan R, Strom S, Halperin SA, Potter AA, Babiuk LA, Gerdts V. Influence of maternal antibodies on active pertussis toxoid immunization of neonatal mice and piglets. Vaccine. 2011 Oct 13; 29(44):7718–26. 
  11. Hill L. 2015. Factors Influencing Women’s Decisions about Having the Pertussis Containing Vaccine during Pregnancy [Masters of Health Science]. Christchurch, New Zealand: University of Otago.

Download

The downloadable PDF version of this article is only available to subscribers.

To view this content please login or subscribe